FDA Wants To Know What Public Thinks About CBD

People have until Sept 13 to submit comments to the FDA about legalizing canabidiol (CBD) – which has documented effectiveness in numerous forms of cancer: https://www.regulations.gov/comment?D=FDA-2017-N-4515-0001

Nwo Report

This is the moment to tell the FDA what you think of cannabidiol (CBD) before it is labelled a scheduled drug and restricted internationally.

By Carey Wedler:

On Monday, the FDA invited the public to submit comments on the potential benefits of cannabidiol (CBD), along with a handful of other substances.

Published in the federal register, the announcement explained that the FDA is “requesting interested persons to submit comments concerning abuse potential, actual abuse, medical usefulness, trafficking, and impact of scheduling changes on availability for medical use of 17 drug substances.” The agency will eventually submit a report including this public input to the World Health Organization, which will use the information to make decisions regarding legal access to the substances. The FDA will collaborate with the Department of Health and Human Services (HHS) to produce the report.

Related: Half Of CBD UsersQuit Prescribed Drugs…

View original post 986 more words

2 thoughts on “FDA Wants To Know What Public Thinks About CBD

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.